close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about MIRM

Recent news which mentions MIRM

< Previous 1 2 3 Next >
Mirum (MIRM) Q1 2026 Earnings Call Transcript
Tickers MIRM
Tags MIRM Recent Press Releases Market News
From Motley Fool
Earnings Scheduled For May 6, 2026
Tickers ABTC ACAD ACNT ACVA
Tags CSGS GLAD WES
From Benzinga
Mirum Pharmaceuticals Rally Reflects Confidence In Late-Stage Liver Disease Assets
Tickers CLNN MIRM NEWS
Tags Health Care News Top Stories
From Benzinga
Deep Dive Into Mirum Pharmaceuticals Stock: Analyst Perspectives (6 Ratings)
Tickers MIRM
Tags Market News Benzinga MIRM
From Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
Tickers EBS ECOR ELDN EXAS
Tags Market News Benzinga BZI/TFM
From Benzinga
Earnings Scheduled For August 6, 2025
Tickers AACG ABNB ACAD ACB
Tags MNKD BKD DAY
From Benzinga
Beyond The Numbers: 4 Analysts Discuss Mirum Pharmaceuticals Stock
Tickers MIRM
Tags MIRM BZI/AAR Analyst Ratings
From Benzinga
Earnings Scheduled For May 7, 2025
Tickers ACAD ACDC ACRE ACVA
Tags NNBR SLNG MDV
From Benzinga
Preview: Mirum Pharmaceuticals's Earnings
Tickers MIRM
Tags Benzinga Earnings Market News
From Benzinga
Earnings Scheduled For February 26, 2025
Tickers A AAOI AAP ABEV
Tags RSI AI XPEL
From Benzinga
FDA Approves Mirum Pharmaceuticals' Drug As First For Genetic Disorder With Inability To Break-Down Cholesterol
Tickers MIRM NEWS
Tags General Biotech Benzinga
From Benzinga
Breaking Down Mirum Pharmaceuticals: 5 Analysts Share Their Views
Tickers MIRM
Tags Analyst Ratings MIRM BZI/AAR
From Benzinga
Earnings Scheduled For November 12, 2024
Tickers ABOS ABSI ACNT ACTG
Tags ALIT PSQH WULF
From Benzinga
Earnings Outlook For Mirum Pharmaceuticals
Tickers MIRM
Tags Market News Earnings Benzinga
From Benzinga
Analyst Expectations For Mirum Pharmaceuticals's Future
Tickers MIRM
Tags BZI/AAR MIRM Analyst Ratings
From Benzinga
MIRM Stock Earnings: Mirum Pharmaceuticals Misses EPS, Beats Revenue for Q2 2024
Tickers MIRM
Tags NASDAQ:MIRM MIRM Earnings Reports
From InvestorPlace
Nvidia To Rally Around 53%? Here Are 10 Top Analyst Forecasts For Tuesday
Tickers ABBV ACN AYI CMG
Tags KR MIRM analyst forecasts
From Benzinga
Why Ovid Therapeutics Shares Are Trading Lower By 19%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Tickers AAN AGRI ALLG AMCX
Tags LRHC KAVL SLS
From Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Tickers ATNF ATRA AVTE BJDX
Tags MBIO MIRM Benzinga
From Benzinga
Mirum Pharmaceuticals Highlights Encouraging Data For Rare Liver Disease Therapy From Two Mid-Stage Studies
Tickers MIRM NEWS
Tags General Biotech why it's moving
From Benzinga
Aaron's, Nvidia, Mirum Pharmaceuticals, Primo Water And Other Big Stocks Moving Higher On Monday
Tickers AAN ADSK GLNG LU
Tags LXRX Movers Intraday Update
From Benzinga
Analyst Ratings For Mirum Pharmaceuticals
Tickers MIRM
Tags Benzinga Market News BZI/AAR
From Benzinga
MIRM Stock Earnings: Mirum Pharmaceuticals Misses EPS, Misses Revenue for Q1 2024
Tickers MIRM
Tags MIRM NASDAQ:MIRM Market News
From InvestorPlace
Analyst Ratings For Mirum Pharmaceuticals
Tickers MIRM
Tags Analyst Ratings BZI/AAR MIRM
From Benzinga
$5M Bet On Snowflake? Check Out These 4 Stocks Insiders Are Buying
Tickers LEGH MG MIRM NEWS
Tags MIRM Small Cap SNOW
From Benzinga
Cracking The Code: Understanding Analyst Reviews For Mirum Pharmaceuticals
Tickers MIRM
Tags Market News Benzinga Analyst Ratings
From Benzinga
FDA Approves Mirum's Livmarli For Liver Disease In Kids As Young As 5 Years: Analyst Bullish On Label Expansion Strategy
Tickers MIRM NEWS
Tags Biotech General News
From Benzinga
Critical Insights From Mirum Pharmaceuticals Analyst Ratings: What You Need To Know
Tickers MIRM
Tags Market News Benzinga Analyst Ratings
From Benzinga
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at $3.75/week.

Subscribe Today